Emergent BioSolutions Earnings
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.93+0.12 (+1.76%)
Market open · Delayed 15 min · as of Oct 9, 1:38 PM ET
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.45
Emergent BioSolutions earnings summary
Emergent BioSolutions is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.45.
Summary generated from market data by MetaCap's automated system. Methodology